Inventor · disambiguated record
Emily I. Chen
Also filed as: CHEN EMILY · CHEN EMILY I
6 granted patents·4 pending applications·49 citations·filing 2001–2022
80Inventor score
Files withUNIV NEW YORK STATE RES FOUND3MILES LINDSEY A2BISSELL MINA J1BURNHAM INST MEDICAL RESEARCH1CHEN EMILY1
Top patents by PatentIndex Score
10 records- 0189US7935785B2Selective substrates for matrix metalloproteinasesSANFORD BURNHAM MED RES INST·Filed 2008·Granted May 3, 2011·11 cites·24 claims
- 0286US7439319B2Selective substrates for matrix metalloproteinasesBURNHAM INST MEDICAL RESEARCH·Filed 2002·Granted Oct 21, 2008·21 cites·38 claims
- 0373US6771401B2Light source module arranged in an image scanning device for scanning a transparent objectMUSTEK SYSTEMS INC·Filed 2001·Granted Aug 3, 2004·15 cites·5 claims
- 0473US2023204583A1Keratins as biomarkers for cervical cancer and survivalUNIV NEW YORK STATE RES FOUND·Filed 2022·Application pending·0 cites
- 0558US2018059112A1Keratins as biomarkers for cervical cancer and survivalUNIV NEW YORK STATE RES FOUND·Filed 2017·Application pending·0 cites
- 0657USRE41018ELight source module arranged in an image scanning device for scanning a transparent objectCHEN EMILY·Filed 2006·Granted Dec 1, 2009·2 cites·41 claims
- 0756US2016187341A1Keratins as biomarkers for cervical cancer and survivalUNIV NEW YORK STATE RES FOUND·Filed 2014·Application pending·0 cites
- 0848US8314212B2Plasminogen receptor PLG-RKT and antibodies thereofMILES LINDSEY A·Filed 2009·Granted Nov 20, 2012·0 cites·2 claims
- 0940US2015079071A1Non-catalytic domain targets in matrix metalloprotease proteins for cancer therapiesBISSELL MINA J·Filed 2013·Application pending·0 cites
- 1039US8680242B2Plasminogen receptor, polypeptides and antibodies thereofMILES LINDSEY A·Filed 2012·Granted Mar 25, 2014·0 cites·3 claims
Join the waitlist — get patent alerts
Get an alert when Emily I. Chen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →